Table of Contents

Select this article
- R Yoshimura,
- E Araki,
- S Ura,
- M Todaka,
- K Tsuruzoe,
- N Furukawa,
- H Motoshima,
- K Yoshizato,
- K Kaneko,
- K Matsuda,
- H Kishikawa,
- and M Shichiri
Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.
Diabetes June 1997 46:929-936; doi:10.2337/diabetes.46.6.929
- Abstract
Select this article
- C Cailleau,
- A Diu-Hercend,
- E Ruuth,
- R Westwood,
- and C Carnaud
Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice.
Diabetes June 1997 46:937-940; doi:10.2337/diabetes.46.6.937
- Abstract
Select this article
- H Noorchashm,
- N Noorchashm,
- J Kern,
- S Y Rostami,
- C F Barker,
- and A Naji
B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.
Diabetes June 1997 46:941-946; doi:10.2337/diabetes.46.6.941
- Abstract
Select this article
- P O Carlsson,
- L Jansson,
- C G Ostenson,
- and O Källskog
Islet capillary blood pressure increase mediated by hyperglycemia in NIDDM GK rats.
Diabetes June 1997 46:947-952; doi:10.2337/diabetes.46.6.947
- Abstract
Select this article
- N Kaiser,
- E M Bailyes,
- B S Schneider,
- E Cerasi,
- D F Steiner,
- J C Hutton,
- and D J Gross
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome.
Diabetes June 1997 46:953-957; doi:10.2337/diabetes.46.6.953
- Abstract
Select this article
- S A Clark,
- C Quaade,
- H Constandy,
- P Hansen,
- P Halban,
- S Ferber,
- C B Newgard,
- and K Normington
Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression.
Diabetes June 1997 46:958-967; doi:10.2337/diabetes.46.6.958
- Abstract
Select this article
- H E Hohmeier,
- H BeltrandelRio,
- S A Clark,
- R Henkel-Rieger,
- K Normington,
- and C B Newgard
Regulation of insulin secretion from novel engineered insulinoma cell lines.
Diabetes June 1997 46:968-977; doi:10.2337/diabetes.46.6.968
- Abstract
Select this article
- J E Kaufmann,
- J C Irminger,
- J Mungall,
- and P A Halban
Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3.
Diabetes June 1997 46:978-982; doi:10.2337/diabetes.46.6.978
- Abstract
Select this article
- D A Pan,
- S Lillioja,
- A D Kriketos,
- M R Milner,
- L A Baur,
- C Bogardus,
- A B Jenkins,
- and L H Storlien
Skeletal muscle triglyceride levels are inversely related to insulin action.
Diabetes June 1997 46:983-988; doi:10.2337/diabetes.46.6.983
- Abstract
Select this article
- N Lahlou,
- P Landais,
- D De Boissieu,
- and P F Bougnères
Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism.
Diabetes June 1997 46:989-993; doi:10.2337/diabetes.46.6.989
- Abstract
Select this article
- J J Nolan,
- B Ludvik,
- J Baloga,
- D Reichart,
- and J M Olefsky
Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
Diabetes June 1997 46:994-1000; doi:10.2337/diabetes.46.6.994
- Abstract
Select this article
- G Perseghin,
- S Ghosh,
- K Gerow,
- and G I Shulman
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.
Diabetes June 1997 46:1001-1009; doi:10.2337/diabetes.46.6.1001
- Abstract
Select this article
- G Perriello,
- S Pampanelli,
- P Del Sindaco,
- C Lalli,
- M Ciofetta,
- E Volpi,
- F Santeusanio,
- P Brunetti,
- and G B Bolli
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.
Diabetes June 1997 46:1010-1016; doi:10.2337/diabetes.46.6.1010
- Abstract
Select this article
- S E Nikoulina,
- T P Ciaraldi,
- L Abrams-Carter,
- S Mudaliar,
- K S Park,
- and R R Henry
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.
Diabetes June 1997 46:1017-1024; doi:10.2337/diabetes.46.6.1017
- Abstract
Select this article
- R J Sigal,
- M El-Hashimy,
- B C Martin,
- J S Soeldner,
- A S Krolewski,
- and J H Warram
Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study.
Diabetes June 1997 46:1025-1029; doi:10.2337/diabetes.46.6.1025
- Abstract
Select this article
- C W Heilig,
- Y Liu,
- R L England,
- S O Freytag,
- J D Gilbert,
- K O Heilig,
- M Zhu,
- L A Concepcion,
- and F C Brosius, 3rd
D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy.
Diabetes June 1997 46:1030-1039; doi:10.2337/diabetes.46.6.1030
- Abstract
Select this article
- A Avogaro,
- F Piarulli,
- A Valerio,
- M Miola,
- M Calveri,
- P Pavan,
- P Vicini,
- C Cobelli,
- A Tiengo,
- L Calò,
- and S Del Prato
Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients.
Diabetes June 1997 46:1040-1046; doi:10.2337/diabetes.46.6.1040
- Abstract
Select this article
- J Vallés,
- M T Santos,
- J Aznar,
- M Velert,
- G Barberá,
- and R Carmena
Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients.
Diabetes June 1997 46:1047-1053; doi:10.2337/diabetes.46.6.1047
- Abstract
Select this article
- C M Simán and
- U J Eriksson
Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats.
Diabetes June 1997 46:1054-1061; doi:10.2337/diabetes.46.6.1054
- Abstract
Select this article
- N Vionnet,
- E H Hani,
- S Lesage,
- A Philippi,
- J Hager,
- M Varret,
- M Stoffel,
- Y Tanizawa,
- K C Chiu,
- B Glaser,
- M A Permutt,
- P Passa,
- F Demenais,
- and P Froguel
Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs.
Diabetes June 1997 46:1062-1068; doi:10.2337/diabetes.46.6.1062
- Abstract
Select this article
- D Owerbach,
- F J Naya,
- M J Tsai,
- S V Allander,
- D R Powell,
- and K H Gabbay
Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31-35.
Diabetes June 1997 46:1069-1074; doi:10.2337/diabetes.46.6.1069
- Abstract
- L Tarnow,
- F Pociot,
- P M Hansen,
- P Rossing,
- F S Nielsen,
- B V Hansen,
- and H H Parving
Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM.
Diabetes June 1997 46:1075-1076
Select this article
- T Yamashita,
- T Murakami,
- M Iida,
- M Kuwajima,
- and K Shima
Leptin receptor of Zucker fatty rat performs reduced signal transduction.
Diabetes June 1997 46:1077-1080; doi:10.2337/diabetes.46.6.1077
- Abstract
Select this article
- M A Glucksmann,
- M Lehto,
- O Tayber,
- S Scotti,
- L Berkemeier,
- J C Pulido,
- Y Wu,
- W J Nir,
- L Fang,
- P Markel,
- K D Munnelly,
- J Goranson,
- M Orho,
- B M Young,
- J L Whitacre,
- C McMenimen,
- M Wantman,
- T Tuomi,
- J Warram,
- C M Forsblom,
- M Carlsson,
- J Rosenzweig,
- G Kennedy,
- G M Duyk,
- and J D Thomas
Novel mutations and a mutational hotspot in the MODY3 gene.
Diabetes June 1997 46:1081-1086; doi:10.2337/diabetes.46.6.1081
- Abstract
Select this article
- T J Kieffer,
- R S Heller,
- C A Leech,
- G G Holz,
- and J F Habener
Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells.
Diabetes June 1997 46:1087-1093; doi:10.2337/diabetes.46.6.1087
- Abstract

Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.

Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice.

B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.

Islet capillary blood pressure increase mediated by hyperglycemia in NIDDM GK rats.

Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome.

Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression.

Regulation of insulin secretion from novel engineered insulinoma cell lines.

Proinsulin conversion in GH3 cells after coexpression of human proinsulin with the endoproteases PC2 and/or PC3.

Skeletal muscle triglyceride levels are inversely related to insulin action.

Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism.

Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.

Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.

Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM.

Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.

Acute postchallenge hyperinsulinemia predicts weight gain: a prospective study.

D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy.

Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients.

Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients.

Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats.

Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs.

Analysis of candidate genes for susceptibility to type I diabetes: a case-control and family-association study of genes on chromosome 2q31-35.

Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM.

Leptin receptor of Zucker fatty rat performs reduced signal transduction.

Novel mutations and a mutational hotspot in the MODY3 gene.

Leptin suppression of insulin secretion by the activation of ATP-sensitive K+ channels in pancreatic beta-cells.

This Issue

Current Issue